Roth Capital Starts Recro Pharma (REPH) at Buy
Tweet
Share
E-mailGet Alerts REPH Hot Sheet
Price: $2.09 --0%
Rating Summary:
10 Buy, 1 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 7 | New: 5
Rating Summary:
10 Buy, 1 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 7 | New: 5
Join SI Premium – FREE
Roth Capital initiated coverage on Recro Pharma (NASDAQ: REPH) with a Buy rating and a price target of $24.00.
For an analyst ratings summary and ratings history on Recro Pharma click here. For more ratings news on Recro Pharma click here.
Shares of Recro Pharma closed at $9.31 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Barclays Starts Hawkins (HWKN) at Equalweight
- Freedom Broker Starts American States Water (AWR) at Hold
- Raymond James Starts Hammond Power Solutions (HPS-A:CN) at Outperform
Create E-mail Alert Related Categories
New CoverageRelated Entities
Roth CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
